Helius medical technologies, inc. (HSDT)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14
Cash flows from operating activities:
Net income (loss)

-15,862

-9,781

-9,565

-8,494

-26,134

-28,623

-27,237

-35,658

-23,511

-28,024

-30,263

-20,312

-17,718

-15,870

-12,183

-7,411

-6,881

-5,091

-5,287

-10,828

-9,838

0

0

0

Adjustments to reconcile net income (loss) to net cash used in operating activities:
Change in fair value of derivative financial instruments

5,828

14,113

13,812

13,984

2,187

-3,577

-1,347

-7,675

-402

-3,443

-6,910

-662

-2,996

-2,510

-1,345

260

2,082

2,044

2,261

-226

-739

0

0

0

Interest accretion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

Interest accretion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-176

0

0

0

Stock-based compensation expense

4,698

4,691

4,186

3,151

8,543

8,095

7,599

7,748

1,963

1,818

2,001

1,975

1,704

2,261

1,905

1,047

1,231

802

1,653

2,467

2,340

0

0

0

Unrealized foreign exchange loss

-632

-70

238

273

542

1,711

1,435

507

-482

-1,585

-1,117

-166

531

-139

-308

236

120

0

0

0

-

-

-

-

Depreciation expense

142

127

108

84

71

59

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Amortization expense

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Provision for doubtful accounts

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Intangible asset impairment

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable

-263

438

0

0

0

-

-

-

-

479

585

711

176

96

50

508

390

126

118

24

8

0

0

0

Other receivables

-46

278

392

-13

-303

-394

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventory

-137

206

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses

335

163

62

102

94

95

-72

-143

-194

-186

0

0

0

-

0

0

-

-

-92

24

110

0

0

0

Other assets

-

-

-

-

-

-

-

-

-

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

Other current assets

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liability

-15

-13

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-368

0

0

0

-

-

-

-

-

-

-

Accounts payable

-1,825

-1,116

-491

1,506

-118

-1,087

-1,427

-2,298

-1,173

1,318

0

0

0

-

-

-

-

-

-

-

-

-

-

-

Accrued liabilities

-642

-327

401

106

225

685

934

969

504

811

0

0

0

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Foreign exchange re-measurement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Net cash used in operating activities

-17,950

-20,999

-21,605

-19,707

-21,561

-19,621

0

0

0

-

-

-

-

-

0

0

-

-

-6,955

-7,926

-6,321

0

0

0

Cash flows from investing activities:
Accounts payable and accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

296

-543

487

0

0

0

-

-

0

0

Shares to be issued

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-10,749

-9,567

0

0

0

-

-

-

-

-

-

-

Purchase of property and equipment

120

278

275

445

574

440

434

274

217

190

0

0

0

-

-

-

-

-

-

-

-

-

-

-

Internally developed software

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from the sale of short term investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

0

378

0

0

0

Net cash used in investing activities

-618

-769

-275

-445

-574

-440

0

0

0

-

-

-

-

-

0

0

-

-

-173

-173

-378

0

0

0

Cash flows from financing activities:
Cash acquired on recapitalization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Proceeds from the issuances of common stock and warrants

0

-

-

-

-

-

-

-

-

-

-

-

17,090

7,848

12,848

13,161

7,777

7,452

2,853

2,549

6,637

0

0

0

Proceeds from the issuance of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Share issuance costs

535

247

1,868

1,889

3,140

3,161

1,345

1,324

82

1,248

1,248

1,248

2,748

1,508

1,508

1,525

141

0

0

0

-

0

0

0

Proceeds from the exercise of stock options and warrants

-

215

241

242

1,002

4,663

6,314

6,764

6,313

2,588

0

0

0

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of convertible debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

632

0

0

0

Proceeds from exercise of stock options and warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

0

-

-

-

-

Proceeds from bridge loan

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Net cash provided by financing activities

4,265

1,653

18,499

18,479

36,388

40,028

0

0

0

-

-

-

-

-

0

0

-

-

3,124

2,636

7,482

0

0

0

Effect of foreign exchange rate changes on cash

7

-9

3

-3

8

54

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net decrease in cash

-14,296

-20,124

-3,378

-1,676

14,261

20,021

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Effect of foreign exchange rate changes on cash

-

-

-

-

-

-

-

-

-

190

337

-151

-202

-110

-70

73

93

-263

-803

-594

-380

0

0

0

Net increase in cash

-

-

-

-

-

-

-

-

-

2,893

0

0

0

-

-

-

-

-

-

-

-

-

-

-

Net increase (decrease) in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,980

7,001

2,225

1,443

-4,807

-6,058

402

0

0

0

Supplemental disclosure of non-cash cash activities
Cash paid for interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

11

11

0

0

0

Cash paid for income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

0

0

0

0